The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Multi-institutional study of allogeneic bone marrow transplantation using myeloablative busulfan (Bu)/fludarabine (Flu) conditioning and short-course, single-agent graft-versus-host disease (GVHD) prophylaxis with high-dose, post-transplantation cyclophosphamide (PTCy).
Christopher George Kanakry
No relevant relationships to disclose
Paul V. O'Donnell
Research Funding - Otsuka
Marcos J.G. De Lima
No relevant relationships to disclose
Wei Wei
No relevant relationships to disclose
Terry Furlong
No relevant relationships to disclose
Marta Medeot
No relevant relationships to disclose
Richard J. Jones
No relevant relationships to disclose
Peter F. Thall
No relevant relationships to disclose
Borje Andersson
Research Funding - Otsuka
Leo Luznik
Research Funding - Otsuka